Pharmafile Logo

What to Consider When Conducting Patient Research in Saudi Arabia

The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.


Conducting market research with patients in any market can be a challenge, requiring sensitivity and consideration for language, culture, religion, as well as for other emotional, behavioural and environmental factors that might impact patients’ behaviour.

In The Kingdom of Saudi Arabia (KSA), where religion and culture are central to society and there are strict laws governing behaviour, patient research can be uniquely challenging. However, as the fastest growing pharma market in the Middle East, it is critical that those who want to leverage opportunities in this Arab state understand patient needs and behaviour. In this article, we will outline the factors to consider when designing a patient research programme, based on our experience and knowledge of the region.

Find out more:
www.researchpartnership.com/news/2016/01/article-what-to-consider-when-conducting-patient-res…


This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Therapy Watch Lupus

Download our latest infographic, which offers an introduction to the real-world patient insights collected by our Therapy Watch Lupus study.

Article: Getting their lives back: Improving options for people with Lupus

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

MedTech specialist joins Research Partnership

Janet Powers has joined the company as a Director in the MedTech division.

Interactive: Best Behaviour

Download our curated collection of case studies and other useful resources that illustrate how we apply the principles of behavioural science in our research design.

RP Investigates - Q&A session: Living with Lupus

In this 45-minute session, Head of Living With, Mariel Metcalfe spoke to Brenda, who was diagnosed with Lupus 12 years ago.

Webcast: Demand Assessment

Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

New syndicated patient report - Living with Lupus US

Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

Video: Emotion AI

Artificial intelligence is revolutionising the way we conduct healthcare market research.

Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.